Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qutenza tolerability with lidocaine or tramadol pre-treatment in peripheral neuropathic pain
NCT01416116Phase 4Completed
- Sponsor
- Astellas Pharma
- Start
- Jul 2011
- Primary completion
- Apr 2012
- Modality
- Transdermal Patches, Small Molecules
- Countries
- 7
01
Overview
A Phase 4 trial of capsaicin 8% patch in Peripheral neuropathic pain, sponsored by Astellas Pharma. Started Jul 2011; status: completed.
02
Drugs
capsaicin 8% patch
03
Conditions
Peripheral neuropathic pain
Beyond the preview
Go deeper on NCT01416116.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01416116.